Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1653
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17906279 | DESIGNER EXTRACELLULAR VESICLES FOR TREATING EXCITOTOXICITY | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 16720840 | Methods and Systems for Platelet Cryopreservation | Non-Final OA | Fenwal, Inc. |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16753634 | Tissue Engineered "Axon Fusion" for Immediate Recovery Following Axon Transection | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17521410 | IDENTIFICATION OF MICROORGANISMS USING MALDI-TOF-MS ON-PLATE EXTRACTION | Non-Final OA | BECTON DICKINSON AND COMPANY |
| 17789999 | FIBROCARTILAGE PREPARATION METHOD USING TENSILE STIMULATION | Final Rejection | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY |
| 18115402 | Wearable Engineered Human Skin and Systems and Methods for Making the Same | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18678139 | Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design | Non-Final OA | The Fynder Group, Inc. |
| 18671703 | Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design | Non-Final OA | The Fynder Group, Inc. |
| 17882488 | Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design | Final Rejection | The Fynder Group, Inc. |
| 17770183 | COMPOSITIONS AND METHODS FOR ENHANCING RETINAL GANGLION CELL DEVELOPMENT AND PLURIPOTENT STEM CELL-DERIVED THREE-DIMENSIONAL TISSUE | Final Rejection | THE TRUSTEES OF INDIANA UNIVERSITY |
| 18583042 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | Final Rejection | NewLeaf Symbiotics, Inc. |
| 17276267 | METHODS OF CONTROLLING ANIMAL PESTS WITH PAENIBACILLUS TERRAE | Non-Final OA | Bayer CropScience LP |
| 18593295 | DEVELOPMENT OF AN ACCELERATED CELLULAR MODEL FOR EARLY CHANGES IN ALZHEIMER’S DISEASE | Non-Final OA | University of Maryland, College Park |
| 17514742 | NON-INVASIVE METHODS FOR SELECTIVELY ENRICHING PLURIPOTENT CELLS | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 18187811 | YEAST INHIBITION WITH BACILLUS SUBTILIS VIA IRON DEPLETION | Final Rejection | Chr. Hansen A/S |
| 18253076 | METHODS OF STABLE VITRIFICATION | Non-Final OA | UPKARA, INC. |
| 16827551 | Seed Endophytes Across Cultivars and Species, Associated Compositions, and Methods of Use Thereof | Final Rejection | Indigo Ag, Inc. |
| 18044092 | Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells | Non-Final OA | Longeveron, Inc. |
| 17906464 | CARDIOSPHERE-DERIVED CELL (CDC) THERAPY FOR THE TREATMENT OF VIRAL INFECTIONS | Final Rejection | Capricor, Inc. |
| 18081431 | AGRICULTURAL COMPOSITIONS COMPRISING MICROBIAL CONSORTIA, AND METHODS OF USE THEREOF | Final Rejection | Microbes, Inc. |
| 17424985 | B CELL IMMUNOTHERAPY | Non-Final OA | Holy Cross Hospital, Inc. |
| 17800932 | SYSTEMS AND METHODS FOR LIVE FISH TISSUE PRESERVATION | Non-Final OA | Finless Foods Inc. |
| 17815435 | ENDOPHYTIC MICROBES FOR GROWTH PROMOTION OF CROP PLANTS AND SUPPRESSION OF AGGRESSIVE INVASIVE PLANT SPECIES, BIOHERBICIDES COMPRISING THE SAME AND METHODS OF USE THEREOF | Non-Final OA | U.S. GEOLOGICAL SURVEY |
| 17851731 | VASCULAR STRUCTURE-CONTAINING LARGE-SCALE BIOLOGICAL TISSUE AND CONSTRUCTION METHOD THEREOF | Non-Final OA | YANSHAN UNIVERSITY |
| 17781173 | NEW USE OF REGEND001 CELL AUTOLOGOUS DELIVERABLE PREPARATION IN TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | Final Rejection | Regend Therapeutics Co., Ltd. |
| 17767324 | CELL SHEET PRODUCTION DEVICE AND CELL SHEET | Final Rejection | MIZUTA Seisakusho, Inc. |
| 17630862 | COMPOSITIONS AND METHODS OF USING MULTIPOTENT STEM CELLS TO REDUCE DISEASE AND ENHANCE WELLNESS | Final Rejection | Xerxez CALILUNG |
| 17623162 | DEVICES AND METHODS FOR THE DETECTION OF BACTERIA | Final Rejection | Transformative Technologies |
| 16991925 | LABYRINTHULOMYCETE STRAINS FOR PRODUCING DOCOSAHEXAENOIC ACID | Non-Final OA | Synthetic Genomics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy